Literature DB >> 3141451

Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans.

G A Brent1, M S LeBoff, E W Seely, P R Conlin, E M Brown.   

Abstract

We employed variable rates of infusion of EDTA or calcium gluconate to examine the relationships between the concentration and rate of change of serum total and plasma ionized calcium and serum immunoreactive intact PTH concentrations in normal subjects. Use of a sensitive immunoradiometric assay specific for PTH-(1-84) made it possible to determine the full range of PTH responses to perturbations in the extracellular calcium concentration. By progressively increasing the rate of administration of calcium gluconate or EDTA during rapid or slow infusions, linear rates of change in the serum calcium concentration were achieved in eight men. The slopes were 2-fold greater during the rapid infusions. Both the calcium infusions decreased serum PTH-(1-84) levels from a mean of 23.2 +/- 2.0 (+/- SE) to 6.4 +/- 1.0 and 5.6 +/- 1.0 ng/L for the rapid and slow infusions, respectively, with no obvious rate dependence. The rapid or slow EDTA infusions increased serum PTH levels to the same maximal extent (95.0 +/- 20.2 and 99.9 +/- 14.5 ng/L, respectively), also with no significant rate dependence. Thus, there was no effect of the rate of change of calcium on the PTH response, which was reflected in similar inverse sigmoidal relationships between PTH and serum total and plasma ionized calcium when the data for the slow and rapid infusions were pooled separately. Similar sigmoidal curves were found in normal women. These data suggest the feasibility of using calcium and EDTA infusions combined with an intact PTH assay to define the relationships between circulating levels of PTH-(1-84) and calcium in states of normal and deranged parathyroid physiology.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141451     DOI: 10.1210/jcem-67-5-944

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  Parathyroid hormone-dependent hypercalcemia.

Authors:  Judit Toke; Attila Patócs; Katalin Balogh; Péter Gergics; Balázs Stenczer; Károly Rácz; Miklós Tóth
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Set point of calcium in severe secondary hyperparathyroidism is altered and does not change after successful kidney transplantation.

Authors:  Jose-Vicente Torregrosa; David Fuster; Carlos Eduardo Duran; Federico Oppenheimer; África Muxí; Domenico Rubello; Francesca Pons; Jose Maria Campistol
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

Review 3.  Calcium-sensing receptor 20 years later.

Authors:  Tariq I Alfadda; Ahmad M A Saleh; Pascal Houillier; John P Geibel
Journal:  Am J Physiol Cell Physiol       Date:  2014-05-28       Impact factor: 4.249

4.  Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects.

Authors:  L Maïmoun; D Simar; D Malatesta; C Caillaud; E Peruchon; I Couret; M Rossi; D Mariano-Goulart
Journal:  Br J Sports Med       Date:  2005-08       Impact factor: 13.800

5.  VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL).

Authors:  Meryl S LeBoff; Amy Y Yue; Trisha Copeland; Nancy R Cook; Julie E Buring; JoAnn E Manson
Journal:  Contemp Clin Trials       Date:  2015-01-24       Impact factor: 2.226

Review 6.  Familial hypocalciuric hypercalcemia and related disorders.

Authors:  Janet Y Lee; Dolores M Shoback
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-05-26       Impact factor: 4.690

7.  Calcium modulation of the renin-aldosterone axis.

Authors:  L Porter; P R Conlin; J Scott; E M Brown; G El-Hajj Fuleihan
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

8.  Suppressibility of serum levels of PTH by calcium in the immediate postoperative period after surgery for primary hyperparathyroidism.

Authors:  A Bergenfelz; B Ahrén
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

9.  Disodium ethylenediaminetetraacetate: adverse effects in dialyzed children.

Authors:  J A Ramirez; W G Goodman; C Menezes; G V Segre; I B Salusky
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

10.  Comparison of the suppressive effect of two doses (500 mg vs 1500 mg) of oral calcium on parathyroid hormone secretion and on urinary cyclic AMP.

Authors:  J Guillemant; S Guillemant
Journal:  Calcif Tissue Int       Date:  1993-11       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.